Delivery Order SPE2DB22D2009-SPE2DB24FM1CP
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA), a defense agency. The $7,177.37 firm fixed price contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, on June 27, 2024, with a completion date of June 28, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,483.24, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024 with a completion date of September 6, 2024. The contract is a delivery order with a firm fixed price pricing type. There is no set-aside designation mentioned. AmerisourceBergen holds significant Indefinite Delivery...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $5,726.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024 with a completion date of September 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is for the delivery of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA). The $10,643.71 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 5, 2024, with a completion date of August 6, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3ml to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $8,815.10. The contract is a Firm Fixed Price Delivery Order and is not associated with any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 mL) to the Defense Logistics Agency (DLA). The $32,903.29 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 5, 2024 and was not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA), a defense agency. The $15,788.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 29, 2024, with an ultimate completion date of August 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 ml to the Defense Logistics Agency (DLA). The $17,149.58 Firm Fixed Price contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 26, 2024 and was awarded on November 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The contract, valued at $3,531.84, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on November 6, 2024. The contract has a completion date of November 7, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,610.97 and a completion date of December 17, 2024. It is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...